Dr. Ildegarda E. Scheidegger, Swiss Art-historian, is a strategic leader and former Sotheby's executive specializing in governance, high-level resource mobilization, and elite stakeholder management. With over 20 years navigating international partnerships and cultural institutions, she helps organizations engage effectively with decision-makers at the highest levels.

Dr. Renato Fassbind is a highly experienced Swiss financial expert and corporate leader, with a distinguished background as CFO of major global corporations and a strong reputation in corporate governance and board leadership. As a non-executive director, he has served on the boards of HSBC, Kühne+Nagel, Swiss Re, and others, and currently serves on the board of Nestlé.

Mikenda is an accomplished executive with a strong background in financial leadership, strategic management, and company establishment. As CFO at Mill Reef Capital, she guided the firm from start-up to operational excellence and previously made key contributions in private equity at Calibrium AG and Adveq Management AG.

Prof. Dr. med. Stefan Pfister is Director of the Preclinical Research Program at the Hopp Children's Cancer Center Heidelberg (KiTZ) and heads the Division of Pediatric Neurooncology at the DKFZ. His research focuses on the genetic and epigenetic characterization of childhood brain tumors. He is a member of the National Academy of Sciences Leopoldina and recipient of the Gottfried Wilhelm Leibniz Award 2023 and the Ammann Award 2026.

Dr. med. Nikola Cihoric is Physician-entrepreneur and radiation oncologist with over 15 years at the intersection of clinical medicine and health technology. He is Founder of Wemedoo AG (Switzerland), where he built oomnia, a unified CDISC/FHIR-aligned clinical trial platform. He also serves as Senior Researcher at Insel Gruppe (University Hospital Bern).